Brigatinib-analog

Brigatinib analog is an orally active, potent, selective inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). Brigatinib analogs bind to and inhibit ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. This results in inhibition of ALK kinase and EGFR kinase, disrupting their signaling pathways and ultimately inhibiting tumor cell growth in susceptible tumor cells.

• Supplier: Alfa Cytology
• Product #: BC0380